APA

van der Noll R., Smit W. M., Wymenga A. N. M., Boss D. S., Grob M., Huitema A. D. R., Rosing H., Tibben M. M., Keessen M., Rehorst H., Beijnen J. H. & Schellens J. H. M. (20160912). Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancer. : Investigational new drugs.

Chicago

van der Noll R, Smit W M, Wymenga A N M, Boss D S, Grob M, Huitema A D R, Rosing H, Tibben M M, Keessen M, Rehorst H, Beijnen J H and Schellens J H M. 20160912. Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancer. : Investigational new drugs.

Harvard

van der Noll R., Smit W. M., Wymenga A. N. M., Boss D. S., Grob M., Huitema A. D. R., Rosing H., Tibben M. M., Keessen M., Rehorst H., Beijnen J. H. and Schellens J. H. M. (20160912). Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancer. : Investigational new drugs.

MLA

van der Noll R, Smit W M, Wymenga A N M, Boss D S, Grob M, Huitema A D R, Rosing H, Tibben M M, Keessen M, Rehorst H, Beijnen J H and Schellens J H M. Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancer. : Investigational new drugs. 20160912.